The author is an analyst of NH Investment & Securities. She can be reached at mj27@nhqv.com. -- Ed. We expect Samyang Foods’ earnings to rebound from 4Q21, backed by a partial easing in shipping congestion and by ASP markup effects. In 2022, the firm is to display a full earnings turnaround, support
Russia's Ministry of Industry and Trade will conduct due diligence on Ilyang Pharmaceutical’s plant that produces “Supect,” a leukemia treatment which also showed efficacy in battling COVID-19, from Sept. 21-25.During this inspection, the Russian ministry will conduct a quality analysis and insp
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. A large number of pharmaceutical/bio players, particularly testing kit companies, have been seeing earnings expansion amid the Covid-19 outbreak. With share prices of related treatment and vaccin
Ilyang Pharmaceutical announced on March 27 that it will start clinical trials in Europe to develop its self-developed drug into a Parkinson's disease (PD) treatment.Ilyang Pharmaceutical recently held a briefing on pre-clinical results at a clinical hospital in France to conduct clinical trials
Ilyang Pharmaceutical announced on March 21 that it will export its seasonal influenza vaccine to Bangladesh, following the Bangladesh health authority’s approval given on March 20.The deal is meaningful for Ilyang as it represent’s its first overseas export after entering the vaccine business.Throu
Il-yang Pharmaceuticals’ leukemia treatment Supect (ingredient name: radotinib) was confirmed to be effective for solid cancers like lung cancer.According to Ilyang Pharmaceuticals on Nov. 15, the company and researchers from Korea University and Sookmyung Women's University have jointly found t
Korean pharmaceutical companies are increasing the sales of their drugs that have not been selling well after development several years ago by improving their functions.According to pharmaceutical industry experts on October 25, the sales of major domestic drugs by the third quarter of this year sig
The Ministry of Food and Drug Safety (MFDS) announced on June 25 that it has banned the sale of Ilyang Pharmaceutical Co.’s antianginal treatment “Simgyeonglac Cap” after detecting excessive lead from the drug. It has ordered the company to recall the product.According to the Korean Pharmacopoeia ac
An increasing number of South Korean pharmaceutical and biotech companies are setting up branches, joint ventures and subsidiaries abroad.Particularly successful examples include Hanmi Pharmaceutical’s Beijing Hanmi Pharmaceutical established in 1996 and Ilyang Pharmaceutical’s Yangzhou Ilyang Pharm
As worries over pandemics of diseases such as the Ebola virus are increasing, achieving “vaccine independence” is becoming an essential criteria to assess the national economy and security.In Korea, however, only ten out of a total of 27 vaccines are produced, and 80 percent, by amount, of vaccines